In elderly patients with poor-prognosis acute myeloid leukaemia (AML), filgrastim may be a beneficial adjunct to supportive care

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1576, 2007-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Myeloid Leukaemia: Optimising Treatment in Elderly Patients

By Jackson G.H.   Taylor P.R.A.  

Drugs & Aging, Vol. 19, Iss. 8, 2002-01 ,pp. : 571-581

Adis International

Access to resources Recommend Favorite

Filgrastim/lenograstim: Acute myeloid leukaemia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1223, 2008-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Economic Analysis of Filgrastim Use for Patients with Acute Myeloid Leukaemia in the UK: A Comparison of Collection Methods of Resource Use Data

By Standaert B.  

PharmacoEconomics, Vol. 20, Iss. 10, 2002-01 ,pp. : 665-674

Adis International

Access to resources Recommend Favorite

Micafungin: Trichosporonosis in elderly patients with acute myeloid leukaemia: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1118, 2006-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite

A reduced-intensity induction regimen for acute myeloid leukaemia (AML) in paediatric patients with Down's syndrome has been evaluated

By  

Inpharma, Vol. 1, Iss. 1618, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite